See a different future with
next generation solutions for growth investing

The coronavirus pandemic crippled the world in 2020 and created much volatility and uncertainty. However, a recovery is on the cards after globally coordinated economic stimulus of unprecedented size, that helped cushion the fall and set the world up for recovery in the days forward. As investors, it is important to keep our eyes on the big picture as short-term anomalies merely accentuate longer term opportunities. 

Markets aside, the major shift in consumer behaviour to adapt to a new normal has also opened up opportunities for investors who are looking for sectors that are primed for growth. We have identified four Megatrends that potentially have the capability and scale to further change the world.

Select icon


Investment Opportunities


The evolution of globalization

Globalization continues to evolve as it did from the exports of raw materials and basic goods in the 15th century to digital goods and services. Today, services, underpinned by technological innovation, are the anchor of global output.
Learn More


The age of digital transformation

Technology has been the agent of change since the tail end of the 20th century. Persistent technological innovation will continue to change the way we work, play, and consume and Investors are well positioned to benefit from this long runway of digital growth.
Learn More


How biotechnology becomes relevant

The fusion of technology and biology has created breakthrough treatments for major killers such as heart diseases and cancer. These advances also complement issues stemming from a greying population that is living longer. The recent COVID-19 vaccine development is a good example of how medical science can help heal the human race.
Learn More


Megacities and the need for infrastructure

Over half the world is living in man-made infrastructure enjoying improved safety standards, sheer physical convenience, and economic advantages over rural living. The infrastructure gap continues to grow across sectors critical to sustaining the urbanization boom.
Learn More

Featured Funds

Capitalize on investment opportunities arising from digital transformation

Franklin Technology Fund

An award-winning fund* that identifies high-quality technology companies with focuses on leading growth themes such as cloud computing services, the internet of things and e-commerce

Fund overview

Invest in leading growth companies located in the US – the world’s largest and most resilient equity market

Franklin U.S. Opportunities Fund

A well-diversified, multi-cap, multi-industry portfolio in leading growth such as technology, biotech and communications.

Fund overview

Invest exclusively in the biotechnology, emerging pharmaceuticals and life science tools/molecular diagnostics sectors

Franklin Biotechnology Discovery Fund

A single-industry-focused fund that seeks potential growth from breakthrough developments in the biotechnology industry.

Fund overview

Tap into an evident multi-year opportunity of infrastructure, a driver of population and economic growth

Legg Mason ClearBridge Infrastructure Value Fund

The award-winning fund^ aims to achieve long-term stable growth of the fund’s value through investment in shares of global infrastructure companies.

Fund overview

Why Franklin Templeton?


We have 1,250+ research and investment professionals on the ground in more than 20 countries.

Specialised Expertise

Our experienced team of analysts span across different fields, offering deep knowledge and access to companies in the portfolios.


Our global research platform is one of the largest in the world. Combining both top-down macro and bottom-up fundamental analysis with quantitative insights, we seek alpha from every angle.

Robust Risk Management

We believe that no single measure or methodology reveals the “truth” about risk. Understanding risk requires a mosaic of analytics, oversight protocols and collaborative consultation with portfolio managers. Therefore, risk management is intrinsic to all aspects of the investment process.

Our Commitment to ESG

Uncovering sustainability factors that help inform an issuer’s credit value and default risk is an integral part of our investment process.

Biotechnology Insights

Technology Insights



The Business of Biotechnology: Capital undercurrents moving the sector

Advances in biotechnology has re-energized the medical application of biology but in many ways, it is capital that is facilitating ...


Biotechnology Innovations Remain at Forefront

A look at why we think biotech companies will remain at the forefront through the pandemic period and beyond.


A Smoother Path to Infrastructure Spending

ClearBridge Investments: Democratic control of the U.S. Senate is a positive for U.S. infrastructure.


Tech Opportunities Abound Amid Economic Reopening

Franklin Equity Group’s Jonathan Curtis says the digital transformation themes that accelerated during the COVID-19 crisis are still just getting started.

Important Information

Franklin Biotechnology Discovery Fund, Franklin Technology Fund and Franklin U.S. Opportunities Fund are sub-funds of Franklin Templeton Investment Funds ("FTIF"), a Luxembourg registered SICAV. Legg Mason ClearBridge Infrastructure Value Fund is a sub-fund of Legg Mason Global Funds plc, an open-ended umbrella investment company constituted in Ireland.

This advertisement or publication has not been reviewed by the Monetary Authority of Singapore.

This webpage is for information only and does not constitute investment advice or a recommendation and was prepared without regard to the specific objectives, financial situation or needs of any particular person who may receive it. This webpage may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any research and analysis contained in this webpage has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. Any views expressed are the views of the fund manager as of the date of this document and do not constitute investment advice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole.

There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from the use of any information, opinion or estimate herein.

The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested.

Past performance is not necessarily indicative nor a guarantee of future performance of the Funds. Subscriptions may only be made on the basis of the most recent Prospectus and Product Highlights Sheet which is available at Templeton Asset Management Ltd or Legg Mason Asset Management Singapore Pte. Limited or authorised distributors of the Funds. Potential investors should read the details of the Prospectus and Product Highlights Sheet before deciding to subscribe for or purchase the Funds. This shall not be construed as the making of any offer or invitation to anyone in any jurisdiction in which such offer is not authorised or in which the person making such offer is not qualified to do so or to anyone to whom it is unlawful to make such an offer.  In particular, the Funds are not available to U.S. citizens, residents or greencard holders.

Investors may wish to seek advice from a financial adviser before making a commitment to invest in shares of the Funds.  In the event an investor chooses not to seek advice from a financial adviser, he/she should consider whether the Funds are suitable for him/her.

Copyright © 2021 Franklin Templeton. All rights reserved. Issued by Templeton Asset Management Ltd, Registration Number (UEN) 199205211E, and Legg Mason Asset Management Singapore Pte. Limited, Registration Number (UEN) 200007942R. Legg Mason Asset Management Singapore Pte. Limited is an indirect wholly owned subsidiary of Franklin Resources, Inc.